Where untapped medical potential and private equity intersect
Princeton Biopharma Capital Partners, LLC, is a private-equity investment firm focused on investing in commercial-stage healthcare companies.
We provide financial and intellectual capital to commercial-stage healthcare companies with products with growth potential that make a significant impact on patients’ lives.
Latest News
- Fidelis Animal Health, Inc. Announces Major Label Expansion for Ethiqa XR®Fidelis Animal Health, Inc. Nov 05, 2024 Ethiqa XR, an extended-release buprenorphine, adds captive rodents and laboratory rabbits to label for… Read more: Fidelis Animal Health, Inc. Announces Major Label Expansion for Ethiqa XR®
- Kaléo Redesigns Commercial Team to Increase Support for AUVI-Q®Richmond, Virginia, Oct. 01, 2024 (GLOBE NEWSWIRE) — Kaléo, a privately-held U.S. pharmaceutical company has announced… Read more: Kaléo Redesigns Commercial Team to Increase Support for AUVI-Q®
- Brittany Mahomes Helps Raise Awareness of Food Allergies in Young ChildrenJan 24, 2024, 08:00 ET RICHMOND, Va., Jan. 24, 2024 /PRNewswire/ — Kaléo, a privately-held pharmaceutical company, is… Read more: Brittany Mahomes Helps Raise Awareness of Food Allergies in Young Children